Castle Biosciences Inc (CSTL)

Castle Biosciences Inc Aktie (CSTL) Neueste Nachrichten

Castle Biosciences CEO Derek Maetzold sells $153k in company stock - Investing.com

Investing.com

Castle Biosciences CEO Derek Maetzold sells $153k in company stock - Investing.com India

Investing.com India

Omega Therapeutics, Inc. (OMGA) Surges 19.6%: Is This an Indication of Further Gains? - Yahoo Movies UK

Yahoo Movies UK

Castle Biosciences Inc [CSTL] Investment Appeal on the Rise – Knox Daily - Knox Daily

Knox Daily

Castle Biosciences to Present at the Leerink Partners Healthcare Crossroads Conference - Yahoo Canada Finance

Yahoo Canada Finance

Castle Biosciences Expands Evidence Supporting the Performance of its TissueCypher® Barrett's Esophagus Test in ... - Yahoo Finance

Yahoo Finance

Castle Biosciences' IDgenetix ® Test Receives 2024 MedTech Breakthrough Award for Best Overall Mental Health ... - Investing.com India

Investing.com India

Castle Biosciences' IDgenetix® Test Receives 2024 MedTech Breakthrough Award for “Best Overall Mental Health ... - Business Wire

Business Wire

Castle Biosciences Announces Closing of Initial Public Offering and Full Exercise of Underwriters' Option to Purchase ... - Yahoo Lifestyle UK

Yahoo Lifestyle UK

Castle Biosciences, Inc. (CSTL) Reports Q4 Loss, Tops Revenue Estimates - Yahoo Movies UK

Yahoo Movies UK

Derek J. Maetzold Sells 2,368 Shares of Castle Biosciences, Inc. (NASDAQ:CSTL) Stock - MarketBeat

MarketBeat

Castle Biosciences CEO sells over $150000 in company stock - Investing.com South Africa

Investing.com South Africa

Castle Biosciences director sells over $570k in company stock - Investing.com India

Investing.com India

Castle Biosciences director sells over $570k in company stock - Investing.com Canada

Investing.com Canada

Castle Biosciences CEO sells over $150000 in company stock - Investing.com

Investing.com

Castle Biosciences director sells over $570k in company stock - Investing.com

Investing.com

Castle Biosciences director sells over $570k in company stock - Investing.com UK

Investing.com UK

Zurcher Kantonalbank Zurich Cantonalbank Boosts Stock Holdings in Castle Biosciences, Inc. (NASDAQ:CSTL) - Defense World

Defense World

Castle Biosciences CEO sells over $150000 in company stock - Investing.com

Investing.com

Wall Street Analysts Predict a 36.09% Upside in Castle Biosciences (CSTL): Here's What You Should Know - Yahoo Finance

Yahoo Finance

Castle Biosciences (CSTL) is on the Move, Here's Why the Trend Could be Sustainable - Yahoo Finance

Yahoo Finance

Earnings Beat: Castle Biosciences, Inc. (NASDAQ:CSTL) Just Beat Analyst Forecasts, And Analysts Have Been Lifting ... - Yahoo Finance

Yahoo Finance

Castle Biosciences, Inc. (NASDAQ:CSTL) Q1 2024 Earnings Call Transcript - Insider Monkey

Insider Monkey

Castle Biosciences, Inc. (NASDAQ:CSTL) Q1 2024 Earnings Call Transcript - Insider Monkey

Insider Monkey

Castle Biosciences First Quarter 2024 Earnings: Beats Expectations - Simply Wall St

Simply Wall St

Castle Biosciences (NASDAQ:CSTL) Price Target Raised to $34.00 - MarketBeat

MarketBeat

Castle Biosciences, Inc. (CSTL) Reports Q1 Loss, Tops Revenue Estimates - Zacks Investment Research

Zacks Investment Research

Castle Biosciences, Inc. (CSTL) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance

Yahoo Finance

Castle Biosciences Reports First Quarter 2024 Results - Business Wire

Business Wire

Castle Biosciences Inc (CSTL) Q1 2024 Earnings: Surpasses Revenue Forecasts and Raises Annual ... - Yahoo Finance

Yahoo Finance

Castle Biosciences Kicks off Skin Cancer Awareness Month with a Ribbon Cutting to Celebrate the City of ... - Business Wire

Business Wire

Castle Biosciences (NASDAQ:CSTL) Trading Up 6.3% - MarketBeat

MarketBeat

Castle Biosciences CEO Derek Maetzold sells shares worth over $22,000 By Investing.com - Investing.com

Investing.com

Castle Biosciences (CSTL) Set to Announce Earnings on Thursday - Defense World

Defense World

Castle Biosciences' Chief Financial Officer Frank Stokes Recognized as a Top CFO of Houston for Second Consecutive ... - citybiz

citybiz

Castle Biosciences Celebrates Esophageal Cancer Awareness Month through Advocacy and Educational Collaborations - Yahoo Finance

Yahoo Finance

Castle Biosciences CEO Derek Maetzold sells shares worth over $137k - Investing.com Canada

Investing.com Canada

Presentations at EADO Highlight Potential Impact of Castle Biosciences' DecisionDx®-Melanoma and DecisionDx ... - Business Wire

Business Wire

Castle Biosciences Secures Loan and Reshuffles Board - TipRanks.com - TipRanks

TipRanks

Castle Biosciences Earns a Top Workplaces USA Award for the Third Consecutive Year - Yahoo Finance

Yahoo Finance

New Study Shows that the Drug-Drug Interactions and Lifestyle Factors Provided by Castle Biosciences' IDgenetix ... - Yahoo Finance

Yahoo Finance

Castle Biosciences to Present New Data Highlighting the Clinical Value of its Dermatologic Tests for Patients with Skin ... - Business Wire

Business Wire

Castle Biosciences, Inc. (NASDAQ:CSTL) Reported Earnings Last Week And Analysts Are Already Upgrading Their ... - Yahoo Finance

Yahoo Finance

Castle Biosciences Full Year 2023 Earnings: Beats Expectations - Yahoo Finance

Yahoo Finance

Why Butterfly Network Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Benzinga

Castle Biosciences, Inc. (NASDAQ:CSTL) Q4 2023 Earnings Call Transcript - Yahoo Finance

Yahoo Finance

Castle Biosciences, Inc. (CSTL) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

Zacks Investment Research

Castle Biosciences, Inc. (CSTL) Reports Q4 Loss, Tops Revenue Estimates

Zacks Investment Research

Castle Biosciences Inc (CSTL) Reports Robust Revenue Growth and Improved Margins in 2023 - Yahoo Finance

Yahoo Finance

Insights Into Castle Biosciences, Inc. (CSTL) Q4: Wall Street Projections for Key Metrics

Zacks Investment Research